EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimized and Functionalized Carvacrol-Loaded Nanostructured Lipid Carriers for Enhanced Cytotoxicity in Breast Cancer Cells

Ana F C Uchôa iD, Allessya L D Formiga iD, Anny L M R Cardoso iD, Graziela M A Pereira, Lucas M M Carvalho iD, Pedro H O Souza iD, Anauara L Silva iD, Ramon R M Souza iD, Marianna V Sobral iD, Marcelo S Silva iD, José M Barbosa-Filho iD, Francisco H Xavier-Júnior iD

Pharmaceutics · 13.03.2025 · 17 (3) · 363

DOI: 10.3390/pharmaceutics17030363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 13.03.2025. Verfasst von Ana F C Uchôa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Paraíba State Research Support Foundation, National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Carvacrol, a monoterpenoid phenol found in essential oils, exhibits many biological activities, including anticancer properties through mechanisms such as induction of apoptosis. These properties can be enhanced if encapsulated within nanoparticles. This study focuses on producing functionalized carvacrol-loaded nanostructured lipid carriers (NLCs) applied to the treatment of breast cancer.

Methods

NLCs were produced by hot emulsification with the sonication method and optimized by the Box–Behnken design, considering Precirol® (1, 4, 7%), carvacrol (1, 5, 9%), and Tween® (0.1, 0.5, 0.9%) as independent variables.

Results

The optimized NLC containing 2% carvacrol had a particle size of 111 ± 2 nm, PdI of 0.26 ± 0.01, and zeta potential of −24 ± 0.8 mV. The solid lipid (Precirol®) was the variable that most influenced particle size. NLCs were functionalized with Pluronic® F68, cholesterol, chitosan, and polyethylene glycol (0.05–0.2%), with oNLC-Chol presenting the most promising results, with no significant increase in particle size (±12 nm) and high encapsulation efficiency (98%). Infrared spectra confirm effective carvacrol encapsulation, and stability tests showed no significant physicochemical changes for 120 days of storage at 4 °C. When incubated with albumin (5 mg/mL), NLCs showed overall good stability over 24 h, except for oNLC-Chol, which increased slightly in size after 24 h. In addition, oNLC increased the cytotoxic effect of carvacrol by 12-fold, resulting in an IC50 of 7 ± 1 μg/mL.

Conclusions

Therefore, it was possible to produce stable, homogeneous NLCs with nanometric sizes containing 2% carvacrol that displayed improved anticancer efficacy, indicating their potential as a delivery system.

Schlagwörter

Stichwörter der Autor:innen

breast cancercarvacroldrug deliverynanostructured lipid carriersnanotechnology

Autor:innen und Institutionen

  • Laboratory of Pharmaceutical Biotechnology (BioTecFarm), Department of Pharmaceutical Sciences, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB,…
  • Multiuser Characterization and Analysis Laboratory (LMCA), Institute of Research in Drugs and Medicines, Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-…
  • Oncopharmacology Laboratory (ONCOFAR), Institute of Research in Drugs and Medicines (IPeFarM), Federal University of Paraiba, Campus Universitário I, Castelo Branco III-Cidade Universitária, João Pessoa 58051-900, PB, B…

ORCID-Profile: Ana F C Uchôa, Allessya L D Formiga, Anny L M R Cardoso, Lucas M M Carvalho, Pedro H O Souza, Anauara L Silva, Ramon R M Souza, Marianna V Sobral, Marcelo S Silva, José M Barbosa-Filho, Francisco H Xavier-Júnior

Förderung

  • Paraíba State Research Support Foundation
  • National Council for Scientific and Technological Development

Zitieren

APA

Uchôa, A. F. C., Formiga, A. L. D., Cardoso, A. L. M. R., Pereira, G. M. A., Carvalho, L. M. M., Souza, P. H. O., Silva, A. L., Souza, R. R. M., Sobral, M. V., Silva, M. S., Barbosa-Filho, J. M., & Xavier-Júnior, F. H. (2025). Optimized and Functionalized Carvacrol-Loaded Nanostructured Lipid Carriers for Enhanced Cytotoxicity in Breast Cancer Cells. Pharmaceutics, 17(3), 363. https://doi.org/10.3390/pharmaceutics17030363

Vancouver

Uchôa AFC, Formiga ALD, Cardoso ALMR, Pereira GMA, Carvalho LMM, Souza PHO, et al. Optimized and Functionalized Carvacrol-Loaded Nanostructured Lipid Carriers for Enhanced Cytotoxicity in Breast Cancer Cells. Pharmaceutics. 2025;17(3):363. doi:10.3390/pharmaceutics17030363

BibTeX
@article{Ucha2025,
  author = {Uchôa, Ana F C and Formiga, Allessya L D and Cardoso, Anny L M R and Pereira, Graziela M A and Carvalho, Lucas M M and Souza, Pedro H O and Silva, Anauara L and Souza, Ramon R M and Sobral, Marianna V and Silva, Marcelo S and Barbosa-Filho, José M and Xavier-Júnior, Francisco H},
  title = {Optimized and Functionalized Carvacrol-Loaded Nanostructured Lipid Carriers for Enhanced Cytotoxicity in Breast Cancer Cells},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {363},
  doi = {10.3390/pharmaceutics17030363}
}
Kostenlos starten →